These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 211756)

  • 21. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 1 virus.
    Burrows R; Goodridge D; Denyer MS
    Vet Rec; 1984 Apr; 114(15):369-74. PubMed ID: 6328728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Not Available].
    Weitere Informationen bei: Albrecht GmbH – ein Unternehmen der Dechra Veterinary Products, 88323 Aulendorf, Tel.: (0 75 25) 205-0, E-Mail: info@dechra.com, www.dechra.de
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2018 Feb; 46(1):65. PubMed ID: 29571207
    [No Abstract]   [Full Text] [Related]  

  • 23. Equine rhinopneumonitis vaccine: immunogenicity and safety in foals.
    Purdy CW; Porter RC; Ford SJ
    Am J Vet Res; 1978 May; 39(5):745-52. PubMed ID: 215062
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro stimulation of foal lymphocytes with equid herpesvirus 1.
    Thomson GR; Mumford JA
    Res Vet Sci; 1977 May; 22(3):347-52. PubMed ID: 195321
    [No Abstract]   [Full Text] [Related]  

  • 25. Demonstration of equine herpes virus 1 (EHV-1) in histological sections and tissue cultures by the peroxidase-antiperoxidase (PAP) technique.
    Gimeno EJ; Nosetto EO; Martin AA; Galosi CM; Ando Y; Etcheverrigaray ME
    Zentralbl Veterinarmed B; 1987 Dec; 34(10):740-2. PubMed ID: 2830744
    [No Abstract]   [Full Text] [Related]  

  • 26. [Application of the passive hemagglutination test to the study of equine rhinopneumonitis. II. Serologic study in horses].
    Berrios P; Ibarra L; Riquelme S
    Rev Latinoam Microbiol; 1986; 28(4):339-43. PubMed ID: 3035677
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of age and pregnancy on the antibody and cell-mediated immune responses of horses to equine herpesvirus 1.
    Gerber JD; Marron AE; Bass EP; Beckenhauer WH
    Can J Comp Med; 1977 Oct; 41(4):471-8. PubMed ID: 200320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody to neuritogenic myelin protein P2 in equine paresis due to equine herpesvirus 1.
    Klingeborn B; Dinter Z; Hughes RA
    Zentralbl Veterinarmed B; 1983 Mar; 30(2):137-40. PubMed ID: 6190332
    [No Abstract]   [Full Text] [Related]  

  • 29. Serological detection of equid herpesvirus 1 infections of the respiratory tract.
    Thomson GR; Mumford JA; Campbell J; Griffiths L; Clapham P
    Equine Vet J; 1976 Apr; 8(2):58-65. PubMed ID: 177281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune escape of equine herpesvirus 1 and other herpesviruses of veterinary importance.
    van der Meulen KM; Favoreel HW; Pensaert MB; Nauwynck HJ
    Vet Immunol Immunopathol; 2006 May; 111(1-2):31-40. PubMed ID: 16472872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).
    Fitzpatrick DR; Studdert MJ
    Am J Vet Res; 1984 Oct; 45(10):1947-52. PubMed ID: 6208822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.
    Patel JR; Földi J; Bateman H; Williams J; Didlick S; Stark R
    Vet Microbiol; 2003 Mar; 92(1-2):1-17. PubMed ID: 12488066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 2 virus.
    Mumford JA; Bates J
    Vet Rec; 1984 Apr; 114(15):375-81. PubMed ID: 6328729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Vaccination against Rhinopneumonia].
    Binkhorst GJ
    Tijdschr Diergeneeskd; 1994 Jan; 119(1):20. PubMed ID: 8291048
    [No Abstract]   [Full Text] [Related]  

  • 35. Induction of a Th-1-biased IgG subclass response against equine herpesvirus type 1 in horses previously infected with type 4 virus.
    Bannai H; Tsujimura K; Kondo T; Nemoto M; Yamanaka T; Sugiura T; Maeda K; Matsumura T
    J Vet Med Sci; 2011 Apr; 73(4):535-9. PubMed ID: 21139350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Equine herpesvirus.
    Collins A
    Vet Rec; 1989 May; 124(18):496. PubMed ID: 2546317
    [No Abstract]   [Full Text] [Related]  

  • 37. Application of a chemically inactivated, adjuvanted vaccine to control abortigenic infection of mares by equine herpesvirus I.
    Bryans JT; Allen GP
    Dev Biol Stand; 1982; 52():493-8. PubMed ID: 6299858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination of mares against equine herpesvirus-1.
    Pickles AC
    Vet Rec; 1992 Feb; 130(8):167-8. PubMed ID: 1314446
    [No Abstract]   [Full Text] [Related]  

  • 39. Agents of equine viral encephalomyelitis: correlation of serum and cerebrospinal fluid antibodies.
    Keane DP; Little PB; Wilkie BN; Artsob H; Thorsen J
    Can J Vet Res; 1988 Apr; 52(2):229-35. PubMed ID: 2836046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections.
    Allen GP; Bryans JT
    Prog Vet Microbiol Immunol; 1986; 2():78-144. PubMed ID: 2856183
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.